EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM

EVALUATION OF SENSITIVITY TO CLOPIDOGREL: THE CURRENT STATE OF THE PROBLEM

The review deals with the laboratory assessment of clopidogrel effect in patients with CHD. The article presents the results of major studies that have demonstrated the relationship between the residual platelet reactivity level and drug pharmacogenetics abnormalities causing coronary complications....

Full description

Bibliographic Details
Main Author:	A. L. Komarov
Format:	Article
Language:	Russian
Published:	«REMEDIUM GROUP» Ltd. 2015-12-01
Series:	Атеротромбоз
Subjects:	фармакогенетика остаточная реактивность тромбоцитов к адф антиагрегантная терапия чрескожные коронарные вмешательства тромбоз
Online Access:	https://www.aterotromboz.ru/jour/article/view/52

Similar Items

The role of clopidogrel in the current treatment of acute coronary syndrome
by: I. S. Yavelov
Published: (2020-06-01)

Prospective registry of percutaneous coronary interventions: Tyumen Cardiology Center’s experience
by: В. А. Кузнецов, et al.
Published: (2015-10-01)

THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY
by: D. A. Andreev
Published: (2015-09-01)

EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE
by: K. B. Mirzaev, et al.
Published: (2015-09-01)

ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS
by: S. T. Matskeplishvili, et al.
Published: (2013-08-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

NICHE OF PRASUGREL AMONG OTHER PLATELET P2Y12-RECEPTOR INHIBITORS
by: P. S. LAGUTA, et al.
Published: (2017-12-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

ДЕТЕРМИНАНТЫ ВЫСОКОЙ И НИЗКОЙ ОСТАТОЧНОЙ РЕАКТИВНОСТИ ТРОМБОЦИТОВ ПРИ ПРИЕМЕ КЛОПИДОГРЕЛА В 1-2 СУТКИ ИНФАРКТА МИОКАРДА
by: Т. П. Пронько, et al.
Published: (2023-09-01)

Physical rehabilitation after percutaneous coronary intervention: new perspectives of rehabilitation programme integration into ambulatory healthcare system
by: N. P. Lyamina, et al.
Published: (1970-01-01)

STATINS IN ACUTE CORONARY SYNDROMES
by: A. L. Alyavi, et al.
Published: (2019-03-01)

Этнические особенности при чрескожных коронарных вмешательствах по данным «Регистра проведенных операций траслюминальной баллонной коронарной ангиопластики»
by: V. A. Kuznetsov, et al.
Published: (2018-04-01)

RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS
by: A. A. Lomonosova, et al.
Published: (2015-12-01)

ТЕСТ ГЕНЕРАЦИИ ТРОМБИНА В ОЦЕНКЕ ДЕЙСТВИЯ АНТИАГРЕГАНТОВ У БОЛЬНЫХ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА ПОСЛЕ ЧРЕСКОЖНОГО КОРОНАРНОГО ВМЕШАТЕЛЬСТВА
by: Г. А. Березовская, et al.
Published: (2015-07-01)

Predictors of long term adverse events after scheduled endovascular coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-08-01)

LONG TERM SURVIVAL OF MYOCARDIAL INFARCTION PATIENTS COMPLICATED WITH CARDIOGENIC SHOCK
by: D. V. Kryuchkov, et al.
Published: (2015-04-01)

New TABAs technique in coronary bifurcation stenosis treatment
by: T. A. Batyraliev, et al.
Published: (1970-01-01)

СОВРЕМЕННЫЕ ПОДХОДЫ К СТРАТИФИКАЦИИ РИСКА БОЛЬНЫХ, ПОДВЕРГАЕМЫХ ПЛАНОВЫМ ЧРЕСКОЖНЫМ КОРОНАРНЫМ ВМЕШАТЕЛЬСТВАМ
Published: (2016-12-01)

Periinterventional cardiovascular risk and the methods for its reduction in coronary heart disease patients undergoing percutaneous coronary intervention
by: K. A. Nazarova, et al.
Published: (1970-01-01)

CLINICAL CHARACTERISTICS OF ISCHEMIC HEART DISEASE PATIENTS WITH TYPE D PERSONALITY, UNDERWENT PERCUTANEOUS CORONARY INTERVENTIONS
by: G. S. Pushkarev, et al.
Published: (2015-06-01)

Stent-Graft Treatment of Anterior Interventricular Artery Extravasation Type IIICS: a Clinical Case
by: M. O. Loginov, et al.
Published: (2020-12-01)

The effect of chlorin e<sub>6</sub> drug on platelet aggregation activity
by: N. N. Petrishchev, et al.
Published: (2019-10-01)

RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA
by: N. F. Putchinyan, et al.
Published: (2015-12-01)

THE ORGANIZATION OF MEDICAL CARE FOR ACUTE CORONARY SYNDROME PATIENTS IN PCI CAPABLE AND PCI NON-CAPABLE HOSPITALS FROM 2009-2012
by: E. V. Oshchepkova, et al.
Published: (2013-06-01)

ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS?
by: Yu. I. Grinshtein, et al.
Published: (2015-09-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

High residual platelet aggregation in patients with coronary artery disease: a new methodological approach to detection
by: O. A. Trubacheva, et al.
Published: (2021-07-01)

IMPACT OF LOCUS 9P21.3 SINGLE NUCLEOTIDE POLYMORPHISMS ON CORONARY ATHEROSCLEROSIS SEVERITY AND LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENT WITH MYOCARDIAL INFARCTION
by: P. A. Shesternya, et al.
Published: (2015-09-01)

Diagnosis aggregation aspirin resistance in patients after myocardial infarction in the secondary prevention of thrombotic complications
by: P P Ogurtsov, et al.
Published: (2012-06-01)

Platelet aggregation under the conditions of vortex flow in vitro in patients with chronic heart failure
by: O. A. Trubacheva, et al.
Published: (2022-07-01)

Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
by: M. P. Mal’gina, et al.
Published: (2007-06-01)

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT
by: A. K. Brel, et al.
Published: (2021-08-01)

COURAGE study results: disappointing or encouraging?
by: D. M. Aronov, et al.
Published: (1970-01-01)

Antiagregantnaya terapiya v pervichnoy i vtorichnoy profilaktike ishemicheskogo insul'ta
by: Al'bert Serafimovich Kadykov, et al.
Published: (2013-09-01)

ANALYSIS OF LONG TERM RESULTS OF MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE WITH A HIGH LEVEL OF TREATMENT ADHERENCE
by: N. Yu. Sokolova, et al.
Published: (2017-08-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Effectiveness of deferred coronary artery stenting in the prevention of no-reflow in patients with acute ST-segment elevation myocardial infarction
by: A. V. Azarov, et al.
Published: (2021-03-01)

EEG-predictor’s effectiveness of starting therapy in epilepsy de novo by adult
by: O. V. Grebenyuk, et al.
Published: (2011-04-01)

DEVELOPMENT OF A CLASSIFICATION OF TYPES OF INDIVIDUAL REACTIVITY AND THE ROLE OF INDIVIDUAL REACTIVITY IN PATHOGENIC PROCESSES
by: Леонид Николаевич Иванов, et al.
Published: (2021-08-01)

EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: A. L. Alyavi, et al.
Published: (2016-01-01)